- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07831044
Analysis of Cerebrospinal Fluid Dynamics in Normal Pressure Hydrocephalus
Analysis of Cerebrospinal Fluid Dynamics in Patients With Normal Pressure Hydrocephalus Using Magnetic Resonance Imaging
This study aims to evaluate whether phase-contrast magnetic resonance imaging (MRI)-based cerebrospinal fluid (CSF) flow dynamics can improve the diagnosis and prognostic assessment of normal pressure hydrocephalus (NPH). In addition, the study investigates how changes in CSF flow parameters before and after CSF diversion procedures are associated with clinical improvement.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Eungseok Oh
- Telefonnummer: 82-42-280-7800
- E-mail: doctor_oh@daum.net
Studiesteder
-
-
Jung-gu
-
Daejeon, Jung-gu, Sydkorea, 35015
- Rekruttering
- Chungnam National University Hospital
-
Kontakt:
- Eungseok Oh
- Telefonnummer: 82-42-280-7800
- E-mail: doctor_oh@daum.net
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients presenting with clinical symptoms consistent with normal pressure hydrocephalus (presence of gait disturbance accompanied by at least one of the following: cognitive impairment or urinary dysfunction)
- Evans' ratio ≥ 0.3 on brain MRI
Exclusion Criteria:
- Patients who cannot undergo CSF drainage due to structural abnormalities of the lumbar spine
- Contraindications to lumbar puncture and CSF drainage (e.g., local infection at the puncture site, suspected elevated intracranial pressure, platelet count < 40,000/µL, or coagulopathy)
- Coexisting neurological disorders that can also cause gait disturbance, such as Parkinson's disease, atypical parkinsonian syndromes, or vascular parkinsonism
- Contraindications to MRI (e.g., presence of cardiac pacemakers, implantable defibrillators, or other non-MRI-compatible implantable medical devices)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Cerebrospinal fluid drainge
|
Cerebrospinal fluid drainge |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline in Cerebrospinal Fluid Flow Velocity (cm/s) at 30 Minutes Post-Procedure
Tidsramme: Baseline (Pre-intervention) and 30 minutes post-intervention
|
Assessment of cerebrospinal fluid flow parameters before and after the procedure. |
Baseline (Pre-intervention) and 30 minutes post-intervention
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline in 10-Meter Walk Test (10MWT) Time at 6 Hours and 24 Hours Post-Procedure
Tidsramme: Baseline, 6 hours post-procedure, and 24 hours post-procedure
|
Completion time during the 10-meter walk test, measured in seconds. |
Baseline, 6 hours post-procedure, and 24 hours post-procedure
|
|
Change from Baseline in 10-Meter Walk Test Step Count at 6 Hours and 24 Hours Post-Procedure
Tidsramme: Baseline, 6 hours post-procedure, and 24 hours post-procedure
|
Number of steps taken during the 10-meter walk test, measured in steps. |
Baseline, 6 hours post-procedure, and 24 hours post-procedure
|
|
Change from Baseline in Timed Up and Go (TUG) Test Time at 6 Hours and 24 Hours Post-Procedure
Tidsramme: Baseline, 6 hours post-procedure, and 24 hours post-procedure
|
Completion time during the 3-meter TUG test, measured in seconds. |
Baseline, 6 hours post-procedure, and 24 hours post-procedure
|
|
Change from Baseline in Cognitive Timed Up and Go (Cognitive TUG) Test Time at 6 Hours and 24 Hours Post-Procedure
Tidsramme: Baseline, 6 hours post-procedure, and 24 hours post-procedure
|
Completion time during the 3-meter Cognitive TUG test while performing a dual task, measured in seconds. |
Baseline, 6 hours post-procedure, and 24 hours post-procedure
|
Samarbejdspartnere og efterforskere
Publikationer og nyttige links
Generelle publikationer
- Sharma AK, Gaikwad S, Gupta V, Garg A, Mishra NK. Measurement of peak CSF flow velocity at cerebral aqueduct, before and after lumbar CSF drainage, by use of phase-contrast MRI: utility in the management of idiopathic normal pressure hydrocephalus. Clin Neurol Neurosurg. 2008 Apr;110(4):363-8. doi: 10.1016/j.clineuro.2007.12.021. Epub 2008 Feb 20.
- Al-Zain FT, Rademacher G, Meier U, Mutze S, Lemcke J. The role of cerebrospinal fluid flow study using phase contrast MR imaging in diagnosing idiopathic normal pressure hydrocephalus. Acta Neurochir Suppl. 2008;102:119-23. doi: 10.1007/978-3-211-85578-2_24.
- Shanks J, Markenroth Bloch K, Laurell K, Cesarini KG, Fahlstrom M, Larsson EM, Virhammar J. Aqueductal CSF Stroke Volume Is Increased in Patients with Idiopathic Normal Pressure Hydrocephalus and Decreases after Shunt Surgery. AJNR Am J Neuroradiol. 2019 Mar;40(3):453-459. doi: 10.3174/ajnr.A5972. Epub 2019 Feb 21.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2025-06-077
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .